Trials / Completed
CompletedNCT02586194
Pharmacokinetics Study in Patients With Impaired Hepatic Function
Pharmacokinetic Study of ASP015K - Evaluation of Pharmacokinetics in Patients With Impaired Hepatic Function and Subjects With Normal Hepatic Function
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to compare and evaluate the pharmacokinetics of ASP015K in patients with impaired hepatic function and subjects with normal hepatic function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP015K | Oral |
Timeline
- Start date
- 2015-12-28
- Primary completion
- 2016-09-27
- Completion
- 2016-09-27
- First posted
- 2015-10-26
- Last updated
- 2024-10-16
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT02586194. Inclusion in this directory is not an endorsement.